AIHealthcare

Imagene AI is a privately held healthcare-AI company focused on precision oncology. Its Oncology Intelligence (OI) Suite and multimodal foundation models integrate histopathology images, molecular and genomic data, clinical outcomes, and proprietary real-world data to support biomarker discovery, patient stratification, treatment-response prediction, companion-diagnostic development, clinical-trial design, and oncology drug development. The company also develops AI-powered pathology assays, including LungOI, an H&E-image-based research-use panel for predicting genomic biomarkers in non-small-cell lung cancer. Reported deployments and validation sites include healthcare and oncology organizations in the United States, Israel, and Latin America. Its stated market position is as a specialist provider of multimodal AI and AI-based molecular profiling for precision oncology, serving biopharma, clinical, and research organizations.